Power of Story
Send a Tweet        
- Advertisement -

Share on Google Plus Share on Twitter 1 Share on Facebook 1 Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend (2 Shares)  

Printer Friendly Page Save As Favorite View Favorites (# of views)   4 comments, 2 series

Companies Rush to Develop 'Utterly Transformative' Gene Therapies -

Quicklink submitted By   Follow Me on Twitter     Message Susan Lee Schwartz     Permalink
Related Topic(s): ; ; ; ; , Add Tags

View Ratings | Rate It

opednews.com Headlined to H4 7/25/17

From commons.wikimedia.org: File:Thecure-logo.svg - Wikimedia Commons1024 Ã-- 493 - 54k - png {MID-145371}
File:Thecure-logo.svg - Wikimedia Commons1024 -- 493 - 54k - png
(Image by commons.wikimedia.org)
  Permission   Details   DMCA

"Gene therapy for cancer is becoming a reality but works best for blood cancers like leukemia and not yet in more common ones like lung cancer. The approval of gene therapy for leukemia, expected in the next few months, will open the door to a radically new class of cancer treatments.Companies and universities are racing to develop these new therapies, which re-engineer and turbocharge millions of a patient’s own immune cells, turning them into cancer killers that researchers call a “living drug.” One of the big goals now is to get them to work for many other cancers, including those of the breast, prostate, ovary, lung and pancreas.But it will take time to find that out, he said, at least five years"

Read the rest of the story HERE:

At www.nytimes.com

- Advertisement -
- Advertisement -